JHM Biopharmaceutical (Hangzhou) Co., Ltd.
PrivateLast Round
Series C
Jun 10, 2026
Total Funding Raised
$114.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
JHM Biopharmaceutical (Hangzhou) Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series C round in June 2026.
JHM Biopharmaceutical (Hangzhou) Co., Ltd. is a biotechnology company that develops recombinant protein drugs and medical devices for endocrinology, neurological disorders, and tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JHM Biopharmaceutical (Hangzhou) Co., Ltd. Comparables
Compare JHM Biopharmaceutical (Hangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Changchun High-tech Industries Group Inc | 78% | |
| Anhui Anke BioTech Group | 75% | |
| Trautec | 75% |
For institutional investors. Book with your work email.
JHM Biopharmaceutical (Hangzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 10, 2026 | ||||
| Series A Extension | Jan 24, 2025 | ||||
| Series B Extension | Sep 10, 2024 | ||||
| Series B | May 8, 2024 | ||||
| Series A | Oct 8, 2022 |
For institutional investors. Book with your work email.
JHM Biopharmaceutical (Hangzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guangdian Capital | Series C, Series A Extension, Series A |
| SDIC Unity Capital | Series B Extension |
| Oriza Holdings | Series B Extension |
| Bencao Capital | Series C, Series A Extension |
| Hongshi Capital | Series A |
| Chengshu Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$29.4M round with Guangdian Capital and Bencao Capital.
- Jan 24, 2025
$15M round led by Guangdian Capital and Bencao Capital.
For institutional investors. Book with your work email.
JHM Biopharmaceutical (Hangzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about JHM Biopharmaceutical (Hangzhou) Co., Ltd.'s valuation, stock price, and market status.
Is JHM Biopharmaceutical (Hangzhou) Co., Ltd. a public or private company?
JHM Biopharmaceutical (Hangzhou) Co., Ltd. is a private company.
What is the current stock price of JHM Biopharmaceutical (Hangzhou) Co., Ltd.?
JHM Biopharmaceutical (Hangzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks JHM Biopharmaceutical (Hangzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is JHM Biopharmaceutical (Hangzhou) Co., Ltd. worth (valuation)?
Valuation information for JHM Biopharmaceutical (Hangzhou) Co., Ltd. is not publicly available.
Can I buy JHM Biopharmaceutical (Hangzhou) Co., Ltd. stock?
JHM Biopharmaceutical (Hangzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was JHM Biopharmaceutical (Hangzhou) Co., Ltd.'s last funding round?
JHM Biopharmaceutical (Hangzhou) Co., Ltd.'s most recent funding round was Series C on June 10, 2026.
Who are the main investors in JHM Biopharmaceutical (Hangzhou) Co., Ltd.?
Key investors in JHM Biopharmaceutical (Hangzhou) Co., Ltd. include Guangdian Capital, SDIC Unity Capital, Bencao Capital.
Will JHM Biopharmaceutical (Hangzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for JHM Biopharmaceutical (Hangzhou) Co., Ltd..
How can I track JHM Biopharmaceutical (Hangzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in JHM Biopharmaceutical (Hangzhou) Co., Ltd.'s shares on secondary markets.